CLINICAL_TRIALS
ClinicalTrials.gov record update
A Randomized, Controlled, Open-Label, Multicenter Phase Ⅲ Clinical Study to Evaluate the Efficacy and Safety of SYS6010 Versus Investigator's Choice Chemotherapy in Patients With Locally Advanced or Metastatic/Recurrent Esophageal Squamous Cell Carcinoma Who Have Failed at Least One Line of Systemic Therapy.
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT07417735
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:28:24.053867+00:00
- Published At
- 2026-02-18T00:00:00+00:00
- Record Updated At
- 2026-02-18
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Locally Advanced/Metastatic/Recurrent ESCC"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-02-18"- protocolSection.identificationModule.nctId
"NCT07417735"- protocolSection.identificationModule.officialTitle
"A Randomized, Controlled, Open-Label, Multicenter Phase \u2162 Clinical Study to Evaluate the Efficacy and Safety of SYS6010 Versus Investigator\u0027s Choice Chemotherapy in Patients With Locally Advanced or Metastatic/Recurrent Esophageal Squamous Cell Carcinoma Who Have Failed at Least One Line of Systemic Therapy."- protocolSection.statusModule.overallStatus
"NOT_YET_RECRUITING"- protocolSection.designModule.phases
["PHASE3"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.